"Pharma-bro" is seemingly back in business
Martin Shkreli is running his old pharmaceutical company from prison with a contraband phone, according to a report.
The “Pharma-bro” criminal – infamous for hiking the price of lifesaving HIV/AIDS drug Daraprim by more than 5,000 per cent in 2015 as well as being the fabled sole owner of an unreleased Wu-Tang Clan album – has allegedly been managing a re-branded version of Turing Pharmaceuticals from behind bars.
The Wall Street Journal claims that Shkreli’s new business behind bars is called Phoenixus, which he hopes will make him “richer” upon leaving prison in 2023 than when he entered.
Shkreli, who is serving a seven-year sentence for defrauding investors in former hedge funds, reportedly uses the phone to read about developments in pharmaceutical research. He apparently also uses it to communicate with company employees including, as per the WSJ report, firing an executive while in jail.
Despite his conviction, for which he was sentenced in March 2018, Shkreli remains a company shareholder at Phoenixus. He is also reportedly under investigation with the FBI for continuing to be involved with the company.
Elsewhere in the WSJ report it’s claimed that Shkreli has been making friends, cutting his own hair with safety scissors, and exercising.
A particular anecdote from the article reads: “He has made prison friends, including ‘Krispy’ and ‘D-Block,’ some of whom affectionately call him ‘Asshole,’ according to people familiar with his new life. They walk alongside him in the hall to ward off shenanigans from other inmates. For reputational reasons they persuaded him to turn down a gig playing guitar in a prison band because the other members were locked up for child molestation.”
Shkreli was reportedly ordered to forfeit the Wu-Tang Clan album as well as an alleged, advanced copy of Lil Wayne’s ‘Tha Carter V’, which was officially released in September 2018 after years of delays.